Suppr超能文献

剖宫产术中预防围手术期寒战的神经轴辅助用药:一项遵循PRISMA指南的网状Meta分析

Neuraxial adjuvants for prevention of perioperative shivering during cesarean section: A network meta-analysis following the PRISMA guidelines.

作者信息

Zhang Yi-Wei, Zhang Juan, Hu Jia-Qi, Wen Chun-Lei, Dai Shu-Yang, Yang Dan-Feng, Li Li-Fang, Wu Qi-Biao

机构信息

State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau 999078, China.

Department of Anesthesiology, First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou 310000, Zhejiang Province, China.

出版信息

World J Clin Cases. 2019 Aug 26;7(16):2287-2301. doi: 10.12998/wjcc.v7.i16.2287.

Abstract

BACKGROUND

Perioperative shivering is clinically common during cesarean sections under neuraxial anesthesia, and several neuraxial adjuvants are reported to have preventive effects on it. However, the results of current studies are controversial and the effects of these neuraxial adjuvants remain unclear.

AIM

To evaluate the effects of neuraxial adjuvants on perioperative shivering during cesarean sections, thus providing an optimal choice for clinical application.

METHODS

A systematic review and network meta-analysis were conducted following the PRISMA (Preferred Reported Items for Systematic Review and Meta-analysis) guidelines. Analyses were performed using Review Manager 5.3 and Stata 14.0. We searched PubMed, EMBASE, Web of Science, and Cochrane Central databases for eligible clinical trials assessing the effects of neuraxial adjuvants on perioperative shivering and other adverse events during cesarean sections. Perioperative shivering was defined as the primary endpoint, and nausea, vomiting, pruritus, hypotension, and bradycardia were the secondary outcomes.

RESULTS

Twenty-six studies using 9 neuraxial adjuvants for obstetric anesthesia during caesarean sections were included. The results showed that, compared with placebo, pethidine, fentanyl, dexmedetomidine, and sufentanil significantly reduced the incidence of perioperative shivering. Among the four neuraxial adjuvants, pethidine was the most effective one for shivering prevention (OR = 0.15, 95%CI: 0.07-0.35, surface under the cumulative ranking curve 83.9), but with a high incidence of nausea (OR = 3.15, 95%CI: 1.04-9.57) and vomiting (OR = 3.71, 95%CI: 1.81-7.58). The efficacy of fentanyl for shivering prevention was slightly inferior to pethidine (OR = 0.20, 95%CI: 0.09-0.43), however, it significantly decreased the incidence of nausea (OR = 0.34, 95%CI: 0.15-0.79) and vomiting (OR = 0.25, 95%CI: 0.11-0.56). In addition, compared with sufentanil, fentanyl showed no impact on haemodynamic stability and the incidence of pruritus.

CONCLUSION

Pethidine, fentanyl, dexmedetomidine, and sufentanil appear to be effective for preventing perioperative shivering in puerperae undergoing cesarean sections. Considering the risk-benefit profiles of the included neuraxial adjuvants, fentanyl is probably the optimal choice.

摘要

背景

围手术期寒战在剖宫产腰麻过程中临床常见,有报道称几种腰麻辅助用药对其有预防作用。然而,目前的研究结果存在争议,这些腰麻辅助用药的效果仍不明确。

目的

评估腰麻辅助用药对剖宫产围手术期寒战的影响,为临床应用提供最佳选择。

方法

按照PRISMA(系统评价和Meta分析优先报告条目)指南进行系统评价和网状Meta分析。使用Review Manager 5.3和Stata 14.0进行分析。我们检索了PubMed、EMBASE、Web of Science和Cochrane Central数据库,以查找评估腰麻辅助用药对剖宫产围手术期寒战及其他不良事件影响的合格临床试验。围手术期寒战被定义为主要终点,恶心、呕吐、瘙痒、低血压和心动过缓为次要结局。

结果

纳入了26项在剖宫产时使用9种腰麻辅助用药进行产科麻醉的研究。结果显示,与安慰剂相比,哌替啶、芬太尼、右美托咪定和舒芬太尼显著降低了围手术期寒战的发生率。在这四种腰麻辅助用药中,哌替啶预防寒战最有效(OR = 0.15,95%CI:0.07 - 0.35,累积排序曲线下面积83.9),但恶心(OR = 3.15,95%CI:1.04 - 9.57)和呕吐(OR = 3.71,95%CI:1.81 - 7.58)的发生率较高。芬太尼预防寒战的效果略逊于哌替啶(OR = 0.20,95%CI:0.09 - 0.43),然而,它显著降低了恶心(OR = 0.34,95%CI:0.15 - 0.79)和呕吐(OR = 0.25,95%CI:0.11 - 0.56)的发生率。此外,与舒芬太尼相比,芬太尼对血流动力学稳定性和瘙痒发生率无影响。

结论

哌替啶、芬太尼、右美托咪定和舒芬太尼似乎对预防剖宫产产妇围手术期寒战有效。考虑到所纳入腰麻辅助用药的风险效益比,芬太尼可能是最佳选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fb/6718794/57742ba22181/WJCC-7-2287-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验